Loading

Envision Healthcare Research Coordinator (February 2015-December 2015)

To satisfy FDA and other government regulations I cannot disclose any research materials. However, please see below for specific research studies which I was the lead researcher during my time at Envision Healthcare

A Phase Ib/IIa Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (lipid injectable emulsion, USP) 20% or Standard-of-Care Soybean Oil-Based Lipid Emulsion. https://clinicaltrials.gov/ct2/show/NCT02476994
A Randomized, Double-blind, Placebo Controlled, Phase 2 Trial of Paclitaxel in Combination with AMG 386 in Subjects with Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer. https://clinicaltrials.gov/ct2/show/NCT00479817
A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women with Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers. https://clinicaltrials.gov/ct2/show/NCT01204749
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 with Paclitaxel and Carboplatin as First-line Treatment of Subjects with FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers. https://clinicaltrials.gov/ct2/show/NCT01493505
Mild Percutaneous Image-Guided Lumbar Decompression versus Epidural Injections in Patient with Lumbar Spinal Stenosis Exhibiting Neurogenic Claudication. https://clinicaltrials.gov/ct2/show/NCT02093520
A Multicenter, Randomized, Double-blind, Controlled, Comparative Study of SI-6603 in Patients with Lumbar Disc Herniation. https://clinicaltrials.gov/ct2/show/NCT00634946
A Double Blind, Randomized, Single Dose, Controlled Study to Compare CHF 5633 (Synthetic Surfactant) and Poractant Alfa in RDS. https://clinicaltrials.gov/ct2/show/NCT02452476

Credits:

Created with an image by Ivana Cajina - "Sunset at Clingmans Dome"